Free Trial

Scienture Q3 2024 Earnings Report

Scienture logo
$1.04 -0.20 (-16.13%)
As of 04/3/2025 04:00 PM Eastern

Scienture EPS Results

Actual EPS
-$1.34
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Scienture Revenue Results

Actual Revenue
$0.07 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Scienture Announcement Details

Quarter
Q3 2024
Time
N/A

Conference Call Resources

Remove Ads

Scienture Earnings Headlines

Scienture CEO says focused on execution, growth, expansion for years ahead
Trump Orders 'National Digital Asset Stockpile'
‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more traction
SCNX Scienture Holdings, Inc.
Scienture appoints Rath as CCO, enters agreement with Syneos
See More Scienture Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Scienture? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Scienture and other key companies, straight to your email.

About Scienture

Scienture (NASDAQ:SCNX) engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

View Scienture Profile

More Earnings Resources from MarketBeat